#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchiectasis Juvenile chronic myelomonocytic leukaemia Glioblastoma Cholangiosarcoma Nephropathy Fatty acid oxidation disorder Paraneoplastic neurological syndrome Hyperoxaluria Cholestatic pruritus Bronchopulmonary aspergillosis Haemophilia Rheumatoid arthritis Dupuytren's contracture Primary amyloidosis Ewing's sarcoma recurrent More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Diagnostics Andersen-Tawil syndrome – Trials in Disease Pemphigus – Treatment Haemophilia B with anti factor IX Leukoencephalopathy – Diagnostics Mucous membrane pemphigoid – Trials in Disease Brain stem glioma – Trials in Disease Pleural mesothelioma malignant – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment Congenital nephrogenic diabetes insipidus – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LTG-001 Perampanel Azd0901 MORPHINE Itepekimab Gallium (68Ga) Io102 Hydrochloride Melphalan Hydrochloride Bevacizumab Zirconium Zr-89 Oleclumab Capecitabine Danazol Futibatinib Casimersen Clascoterone Ianalumab Ag13909 GEN1078 RO7268489 Ecoo25B More therapies…

    Learn about Your Condition

    Vestibular disorder Combined immunodeficiency Periodontitis Stem cell transplant Pyelonephritis acute Drug use disorder Gastrointestinal disorder Mitral valve disease Deafness traumatic Small cell carcinoma Non-small cell lung cancer Type 2 diabetes mellitus Acromegaly Follicular lymphoma stage IV Lichen planus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Health Care Quality, Access, and Evaluation

  • Study on the Effects of Acetylsalicylic Acid and Cytisine for High-Risk Patients in Preventing Lung Cancer and Reducing Inflammation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cytisine
    • Acetylsalicylic Acid
    Italy

  • Study on the Effects of DHEA and Melatonin on Sleep and Mood in Postmenopausal Women with Sleep Disorders

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Menopause
    • Sleep disorder
    Investigated Drugs:
    • Melatonin
    • Prasterone
    Poland

  • Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Albumin Solution
    • Tinzaparin Sodium
    • Dalteparin Sodium
    Denmark Finland Iceland The Netherlands Sweden

  • Study on the Effect of Prasterone on Genitourinary Syndrome in Postmenopausal Women with a History of Breast Cancer or Undergoing Anti-Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Genitourinary syndrome of menopause
    • Breast cancer
    Investigated Drugs:
    • Prasterone
    Italy

  • Study of different ropivacaine concentrations in ankle nerve block for hallux valgus (bunion) surgery patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Foot deformity
    Investigated Drugs:
    • Ropivacaine
    Belgium

  • Study on Sedation During Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis Using Remifentanil, Dexmedetomidine, and Propofol

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Remifentanil
    • Ketamine Hydrochloride
    • Propofol
    Italy
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!